Skip to main content

Schizophrenia & Psychotic Disorders

The suicide rate among people with schizophrenia spectrum disorders is 170 times higher than in the general population, according to a study published online in the journal Schizophrenia Research.
In this video, psychiatrist Richard Jackson, MD, speaks about assessing and monitoring tardive dyskinesia during telepsychiatry visits.
In this video, Leslie Citrome, MD, MPH, details 5 steps to success for clinicians treating patients who have tardive dyskinesia or are at risk of the disorder.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, offers guidance on the proper treatment of tardive dyskinesia (TD) during the COVID-19 pandemic.
Patients who switched from risperidone to lurasidone experienced reductions in several adverse effects, proportionate to increases experienced while on risperidone, according to a study in BMC Psychiatry.
What does in utero malnutrition have to do with schizophrenia? And why is weight gain, a problematic adverse event, also linked with clinical effectiveness of antipsychotic medications? 
Why do so many antipsychotic medications induce symptoms, signs, and physiologic changes that are already present to a lesser degree in the disease states that they are intended to treat?
Back to Top